Publications & Posters – 2024

Subscribe to our updates
  • All
  • HMBD-001
  • HMBD-002
  • Posters
Posters

24 October, 2024

EORTC-NCI-AACR 2024: A novel HER2 targeted dual-payload ADC, HMBD‑802 overcomes resistance to topoisomerase 1 inhibitor ADCs

Posters

17 October, 2024

Festival of Biologics 2024: The Hummingbird Abvantage™: Engineering immune responses for epitope-focused antibody discovery

Posters

10 September, 2024

WCLC 2024: A Phase Ib Study to Evaluate HMBD‑001 in Combination with Docetaxel with or without Cetuximab in Participants with Advanced Squamous Non-Small Cell Lung Cancers, and HMBD‑001 in Combination with Cetuximab in Participants with Advanced Squamous Cell Cancers

Posters

25 April, 2024

AACR 2024: The VISTA blocking antibody HMBD-002 promotes type-I interferon signaling and drives anti-tumor responses through macrophage reprograming and cytotoxic CD8+ T cell activation

Posters

25 April, 2024

AACR 2024: A HER3 antibody that uniquely blocks the HER3 heterodimerization interface effectively inhibits tumor growth in pre-clinical models with potentially oncogenic HER3 mutations

Load more
All Years 2025 2024 2023 2022 2021 2020 2019 2018 2017